Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03232450Withdrawn
Randomised, open-label trial in patent foramen ovale (PFO), sponsored by Mayo Clinic. Primary endpoint: Number of Embolic Brain Lesions Detected on MRI >3 mm at 1 year. Planned start Aug 2019; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03232450.